Gary Cheung

Dr. Gary Cheung

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2020 in Aging & Mental Health
Verified
Journal Article
Closed access
GCGary Cheung
Gary Cheung
KPKathryn Peri
Kathryn Peri
(2020). Challenges to dementia care during COVID-19: Innovations in remote delivery of group Cognitive Stimulation Therapy. Aging & Mental Health. Ahead of Print.

10 October 2023 in Psychiatry Research
Verified
Journal Article
Open access
MSMengke Shi
Mengke Shi
GCGary Cheung
Gary Cheung
Seyed Reza ShahamiriSeyed Reza Shahamiri
Seyed Reza Shahamiri
Dementia is a progressive neurodegenerative disease that burdens the person living with the disease, their families, and medical and social services. Timely diagnosis of dementia could be followed by introducing interventions that may slow down its progression or reduce its burdens. However, the diagnostic process of dementia is often complex and resource intensive. Access to diagnostic services is also an issue in low and middle-income countries. The abundance and easy accessibility of speech and language data have created new possibilities for utilizing Deep Learning (DL) technologies to be part of the dementia diagnostic process. This systematic review included studies published between 2012-2022 that utilized such technologies to aid in diagnosing dementia. We identified 72 studies using the PRISMA 2020 protocol, extracted and analyzed data from these studies and reported the related DL technologies. We found these technologies effectively differentiated between healthy individuals and those with a dementia diagnosis, highlighting their potential in the diagnosis of dementia. This systematic review provides insights into the contributions of DL-based speech and language techniques to support the dementia diagnostic process. It also offers an understanding of the advancements made in this field thus far and highlights some challenges that still need to be addressed.

20 January 2015 in International Psychogeriatrics
Verified
Journal Article
Open access
PDF file
GCGary Cheung
Gary Cheung
ACA. Clugston
A. Clugston
MCM. Croucher
M. Croucher
DMD. Malone
D. Malone
EME. Mau
E. Mau
SGS. Gee
S. Gee
Background: With the ubiquitous Mini-Mental State Exam now under copyright, attention is turning to alternative cognitive screening tests. The aim of the present study was to investigate three common cognitive screening tools: the Montreal Cognitive Assessment (MoCA), the Rowland Universal Dementia Assessment Scale (RUDAS), and the recently revised Addenbrooke's Cognitive Assessment Version III (ACE-III). Methods: The ACE-III, MoCA and RUDAS were administered in random order to a sample of 37 participants with diagnosed mild dementia and 47 comparison participants without dementia. The diagnostic accuracy of the three tests was assessed. Results: All the tests showed good overall accuracy as assessed by area under the ROC Curve, 0.89 (95% CI = 0.80–0.95) for the ACE-III, 0.84 (0.75–0.91) for the MoCA, and 0.86 (0.77–0.93) for RUDAS. The three tests were strongly correlated: r(84) = 0.85 (0.78–0.90) between the ACE-III and MoCA, 0.70 (0.57–0.80) between the ACE-III and RUDAS; and 0.65 (0.50–0.76) between the MoCA and RUDAS. The data derived optimal cut-off points for were lower than the published recommendations for the ACE-III (optimal cut-point ≤76, sensitivity = 81.1%, specificity = 85.1%) and the MoCA (≤20, sensitivity = 78.4%, specificity = 83.0%), but similar for the RUDAS (≤22, sensitivity = 78.4%, specificity = 85.1%). Conclusions: All three tools discriminated well overall between cases of mild dementia and controls. To inform interpretation of these tests in clinical settings, it would be useful for future research to address more inclusive and potentially age-stratified local norms.

1 October 2015 in Journal of Affective Disorders
Verified
Journal Article
Closed access
GCGary Cheung
Gary Cheung
SMSally Merry
Sally Merry
FSFrederick Sundram
Frederick Sundram

1 December 2017 in Journal of Pain and Symptom Management
Verified
Journal Article
Closed access
GCGary Cheung
Gary Cheung
GDGwendolyn Douwes
Gwendolyn Douwes
FSFrederick Sundram
Frederick Sundram

7 September 2022 in BMJ Open
Verified
Journal Article
Open access
PDF file
GCGary Cheung
Gary Cheung
ETEdith To
Edith To
CRClaudia Rivera-Rodriguez
Claudia Rivera-Rodriguez
EMEtuini Ma’u
Etuini Ma’u
ACAmy Hai Yan Chan
Amy Hai Yan Chan
SCSarah J. Cullum
Sarah J. Cullum
Objective Estimates of dementia prevalence in New Zealand (NZ) have previously been extrapolated from limited Australasian studies, which may be neither accurate nor reflect NZ’s unique population and diverse ethnic groups. This study used routinely collected health data to estimate the 1-year period prevalence for diagnosed dementia for each of the 4 years between July 2016 and June 2020 in the age 60+ and age 80+ populations and for the four main ethnic groups. Design A population-based descriptive study. Setting Seven national health data sets within the NZ Integrated Data Infrastructure (IDI) were linked. Diagnosed dementia prevalence for each year was calculated using the IDI age 60+ and age 80+ populations as the denominator and also age–sex standardised to allow comparison across ethnic groups. Participants Diagnosed dementia individuals in the health datasets were identified by diagnostic or medication codes used in each of the data sets with deduplication of those who appeared in more than one data set. Results The crude diagnosed dementia prevalence was 3.8%–4.0% in the age 60+ population and 13.7%–14.4% in the age 80+ population across the four study years. Dementia prevalence age–sex standardised to the IDI population in the last study period of 2019–2020 was 5.4% for Māori, 6.3% for Pacific Islander, 3.7% for European and 3.4% for Asian in the age 60+ population, and 17.5% for Māori, 22.2% for Pacific Islander, 13.6% for European and 13.5% for Asian in the age 80+ population. Conclusions This study provides the best estimate to date for dementia prevalence in NZ but is limited to those people who were identified as having dementia based on data from the seven included data sets. The findings suggest that diagnosed dementia prevalence is higher in Māori and Pacific Islanders. A nationwide NZ community-based dementia prevalence study is much needed to confirm the findings of this study.